Tci Wealth Advisors, Inc. Axsome Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$58.39 - $75.0 $2,277 - $2,925	39 Added 56.52%	108 $6,000
Q4 2022 Feb 06, 2023	BUY	$39.94 - $79.72 $2,755 - $5,500	69 New	69 $5,000
Q2 2022 Jul 19, 2022	SELL	$21.74 - $46.75 $2,674 - $5,750	-123 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$30.7 - $43.36 $1,258 - $1,777	41 Added 50.0%	123 $5,000
Q3 2021 Oct 29, 2021	BUY	$19.91 - $68.26 $497 - $1,706	25 Added 43.86%	82 $3,000
Q2 2021 Aug 02, 2021	BUY	$50.63 - $73.5 $1,113 - $1,617	22 Added 62.86%	57 $4,000
Q1 2021 Apr 29, 2021	BUY	$55.91 - $81.44 $1,956 - $2,850	35 New	35 $2,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.